Manchester lands £500m R&D investment as science parks attract global capital
Manchester in the UK has secured a £500 million R&D commitment from UK medical device company Convatec, underlining the appeal of urban innovation districts and helping position science parks as a maturing real estate asset class.
You have reached premium content
Our readers look to Real Asset Insight to stay informed about the issues that matter in the real asset markets. Log in, start a free trial or subscribe below.
Stay ahead of your competitors with the latest news, market insights and in-depth analysis of the issues that matter in Real Assets.
45 DAY TRIAL MEMBERSHIP
Be part of the leading real asset community!
Get your free trial now
SUBSCRIBE NOW
Stay ahead of your competitors with the latest news, market insights and in-depth analysis of the issues that matter in Real Assets.
Be part of the leading real asset community and subscribe now!
Subscribe now
